Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Vinter

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|March 28, 2006
Molecular field extrema as descriptors of biological activity: definition and validationTim Cheeseright, Mark Mackey, Sally Rose, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Molecular field technology applied to virtual screening and finding the bioactive conformationTim Cheeseright, Mark Mackey Phd, Sally Rose Phd, et al.
Journal of Computer-Aided Molecular Design|August 23, 2019
How computational chemistry develops: a tribute to Peter GoodfordGabriele Cruciani, Yvonne Martin, Andy Vinter, et al.
Chemical Communications (Cambridge, England)|May 1, 2010
An efficient asymmetric synthesis of the potent beta-blocker ICI-118,551 allows the determination of enantiomer dependency on biological activityJames R Baker, J Daniel Hothersall, Richard J Fitzmaurice, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitorsScott P Webster, Peter Ward, Margaret Binnie, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazolesScott P Webster, Margaret Binnie, Kirsty M M McConnell, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|March 28, 2006
Molecular field extrema as descriptors of biological activity: definition and validationTim Cheeseright, Mark Mackey, Sally Rose, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Molecular field technology applied to virtual screening and finding the bioactive conformationTim Cheeseright, Mark Mackey Phd, Sally Rose Phd, et al.
Journal of Computer-Aided Molecular Design|August 23, 2019
How computational chemistry develops: a tribute to Peter GoodfordGabriele Cruciani, Yvonne Martin, Andy Vinter, et al.
Chemical Communications (Cambridge, England)|May 1, 2010
An efficient asymmetric synthesis of the potent beta-blocker ICI-118,551 allows the determination of enantiomer dependency on biological activityJames R Baker, J Daniel Hothersall, Richard J Fitzmaurice, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitorsScott P Webster, Peter Ward, Margaret Binnie, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazolesScott P Webster, Margaret Binnie, Kirsty M M McConnell, et al.
Pageof 1